Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-08-29 to 2024-08-30
Current total value of award: $1404.48
Description: 4565626826!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML